|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 90 No. 7 (October 1), 1997:
pp. 2772-2783
Regulation of Neutrophil Apoptosis by Tumor Necrosis Factor- : Requirement for TNFR55 and TNFR75 for Induction of Apoptosis In Vitro
By
Joanna Murray,
Jeffrey A.J. Barbara,
Sarah A. Dunkley,
Angel F. Lopez,
Xaveer Van Ostade,
Alison M. Condliffe,
Ian Dransfield,
Christopher Haslett, and
Edwin R. Chilvers
From the Respiratory Medicine Unit, the Department of Medicine (RIE), University of Edinburgh, Rayne Laboratory, Medical School, Edinburgh, UK; the Division of Human Immunology, Hanson Centre for Cancer Research/Institute of Medical and Veterinary Science, Adelaide, South Australia; and VIB, Laboratory for Medical Protein Chemistry, University of Ghent, Ghent, Belgium.
 |
ABSTRACT |
Granulocyte apoptosis is an important mechanism underlying the removal of redundant neutrophils from an inflammatory focus. The ability of many proinflammatory agents to impede this event suggests that such agents act not only in a priming or secretagogue capacity but also increase neutrophil longevity by delaying apoptosis. We have examined whether this hypothesis holds true for all neutrophil priming agents, in particular tumor necrosis factor- (TNF-), which has been variably reported to either induce, delay, or have no effect on neutrophil apoptosis. After 20 hours coincubation TNF- inhibited neutrophil apoptosis; however, more detailed analysis demonstrated its ability to promote apoptosis in a subpopulation of cells at earlier (2 to 8 hours) times. Formyl-Met-Leu-Phe, platelet-activating factor, inositol hexakisphosphate, lipopolysaccharide, leukotriene B4 , and granulocyte-macrophage colony-stimulating factor all inhibited apoptosis at 6 and 20 hours. The early proapoptotic effect of TNF- was concentration-dependent (EC50 2.8 ng/mL), abolished by TNF- neutralizing antibody, and was not associated with any change in cell viability or recovery. Of relevance to the inflamed site, the ability of TNF- to accelerate apoptosis was lost if neutrophils were primed with 1 µmol/L PAF or aged for 6 hours before TNF- addition. The TNFR55-selective TNF- mutants (E146K, R32W-S86T) induced neutrophil apoptosis but with a potency 14-fold lower than wild-type TNF-. Although the TNFR75-selective mutant (D143F ) did not induce apoptosis, blocking antibodies to both receptor subtypes abolished TNF--stimulated apoptosis. Hence, TNF- has the unique ability to induce apoptosis in human neutrophils via a mechanism where TNFR75 facilitates the dominant TNFR55 death effect. This may be an important mechanism controlling neutrophil longevity and clearance in vivo.
| |
INTRODUCTION |
NEUTROPHIL APOPTOSIS, which results in the recognition and uptake of these cells by macrophages, has been proposed as an important mechanism for the removal of neutrophils from sites of inflammation.1-6 Experimental data obtained using human peripheral blood neutrophils show that these cells undergo constitutive apoptosis when aged in vitro and that this process is associated with maintenance of membrane integrity, hyporesponsiveness to external secretagogue signals, and the capacity to be phagocytosed intact by macrophages and certain other cells with phagocytic potential.1-5,7 The speed and capacity of the macrophage phagocytic response toward apoptotic neutrophils, together with the observation that engulfment does not excite a proinflammatory macrophage response,8 predicts that this process plays an important role in the safe disposal of intact but effete neutrophils from an inflamed focus. This view is supported by the recent demonstration of this process occurring in vivo; for example, in endotoxin-induced experimental lung injury,9 the neonatal respiratory distress syndrome,10 and experimental glomerulonephritis.11
Although the mechanisms involved in regulating neutrophil survival and death are poorly understood, there is now considerable evidence to suggest that this process is not immutable because the rate at which these cells undergo apoptosis, at least in vitro, can be altered. For example, the colony-stimulating factors granulocyte colony-stimulating factor (G-CSF ) and granulocyte-macrophage-CSF (GM-CSF ), lipopolysaccharide (LPS), and hypoxia all increase the survival of these cells by delaying apoptosis12-17 implying that certain agents may upregulate neutrophil function both by priming for enhanced functional responsiveness to secretagogue agonists and by delaying apoptosis which prolongs their functional life span.16
One cytokine of particular interest in this paradigm is tumour necrosis factor- (TNF-). This agent is a powerful priming agonist in neutrophils yet has the capacity along with other low-affinity nerve growth factor (NGF ) receptor ligands to induce apoptosis in a variety of cells, including T lymphocytes18 and HL-60 cells.19 In contrast, a number of reports have indicated that TNF- has the opposite effect, ie, delays apoptosis, in human monocytes, neutrophils, and B104 lymphoma cells.20-22 Interest in this area has been heightened by the recent finding of Zheng et al,18 who showed that the induction of apoptosis in CD8+ T cells by TNF- is mediated via the TNFR75 rather than the classical death domain-containing TNFR55.23
The aim of this study was to undertake a detailed characterization of the effects of TNF- on neutrophil apoptosis in vitro. We show that while prolonged incubation (>12 hours) of human neutrophils with TNF- indeed causes a decrease in the extent of apoptosis, TNF- can induce apoptosis in a proportion of cells at earlier times (<8 hours). The early proapoptotic effect of TNF- (1) appears to be unique to this cytokine because it is not observed with other priming or secretagogue agonists, (2) is abolished by initial priming of the cells with platelet-activating factor (PAF ), an effect that is not secondary to a change in TNFR55 or TNFR75 expression, and (3) appears critically dependent on TNF- interaction with both TNF receptor subtypes as determined by blocking TNF- receptor antibodies and TNF- mutants which display selective binding to the two TNF- receptors.24-26
View larger version (18K):
[in this window]
[in a new window]
| Fig 1.
Time course for the effect of TNF- on apoptosis in human neutrophils. Human neutrophils (5 × 106/mL) were incubated in MDM containing 10% autologous serum alone ( ), or in the presence of 25 ng/mL TNF- ( ) or 50 U/mL GM-CSF ( ) at 37°C. At the time periods indicated, the cells were resuspended and cytocentrifuge preparations made. These were fixed, stained, and percent apoptosis assessed morphologically. (A) Represents the effects of TNF- after 3, 6, 12, and 20 hours of incubation with the results from a separate series of experiments over a 1- to 8-hour time course shown in (B). The comparative effects of GM-CSF on neutrophil apoptosis at 6 and 20 hours are shown in (C). All values represent mean ± SEM of n = 3 separate experiments, each performed in triplicate (*P < .05 compared with time-matched controls). Where not shown, SEM values are less than 2% of means.
|
|
View larger version (132K):
[in this window]
[in a new window]
View larger version (134K):
[in this window]
[in a new window]
View larger version (19K):
[in this window]
[in a new window]
| Fig 2.
Effect of TNF- on neutrophil morphology and propidium iodide (PI) staining. Human neutrophils were incubated in the presence (A and B, righthand panels) or absence (A and B, lefthand panels) of 12.5 ng/mL TNF- as detailed in the legend to Fig 1. (A) Cytocentrifuge preparations were prepared after 6 hours and cells fixed, stained, and examined under 100× objective oil immersion light microscopy. Cells with classical apoptotic morphology are arrowed. (B) After 6 or 20 hours in culture cells were resuspended in ice-cold 70% ethanol, washed in PBS, and incubated with PI in the presence of RNAase before analysis using an EPICS Profile II. Mean fluorescence values are shown for a minimum of 5,000 cells for each condition and are representative of six to nine determinations in three separate experiments.
|
|
| |
MATERIALS AND METHODS |
Neutrophil preparation and culture.
Human neutrophils were purified from the peripheral blood of healthy human volunteers exactly as detailed previously.27 Cell purity was assessed using cytocentrifuge preparations fixed in methanol and stained with May/Grünwald/Giemsa (Merck Ltd, Lutterworth, Leicestershire, UK) and was routinely greater than 95% neutrophils with less than 0.1% mononuclear cell contamination. Viability was assessed by the ability of the cells to exclude trypan blue and was consistently greater than 99% under all experimental conditions reported. Freshly harvested neutrophils were routinely suspended at a density of 5 × 106/mL in Iscove's modified Dulbecco's medium (MDM) supplemented with 10% autologous serum and 50 U/mL penicillin and streptomycin and cultured at 6.75 × 105 cells/150 µL in flat-bottomed 96-well Falcon flexiwell plates (Becton Dickinson, Oxford, UK) in a humidified 5% CO2 atmosphere at 37°C.
To examine the effects of neutrophil priming agents, freshly isolated cells were cultured in the presence or absence of (final concentrations) formyl-Met-Leu-Phe (fMLP) (1 nmol/L), PAF (1 µmol/L), inositol hexakisphosphate (InsP6 ; 100 µmol/L), LPS (100 ng/mL), leukotriene B4 (LTB4 ; 100 nmol/L), GM-CSF (50 U/mL), or TNF- (0.005 to 100 ng/mL). After incubation for the time periods indicated (1 to 20 hours), apoptosis was quantified as detailed below.
Morphological assessment of PMN apoptosis.
After gentle resuspension, neutrophils were harvested, cytocentrifuged, and the resulting slide preparations fixed and stained as described above with cell viability (trypan blue exclusion) and recovery assessed in parallel. Cell morphology was examined under oil immersion light microscopy, and apoptotic neutrophils defined as cells containing darkly stained pyknotic nuclei.1 For each condition examined, slides were prepared from triplicate incubations and a total of at least 500 neutrophils covering five high-power fields counted with the observer blinded to the assay conditions.
Chromatin fragmentation assay and propidium iodide staining.
For preparation of genomic DNA, neutrophils were incubated in the presence or absence of 1 to 100 ng/mL TNF- or 10 and 100 ng/mL E146K and D143F for 3 hours, pelleted, and resuspended in 2 mL 150 mmol/L sodium acetate, 5 mmol/L EDTA (pH 7). After addition of a further 2 mL of sodium acetate/EDTA containing 0.2 mg/mL proteinase K and 1% sodium dodecyl sulphate (SDS) the samples were incubated overnight at 55°C. Fresh proteinase K (0.1 mg/mL) was added and samples were incubated for a further 1 hour at 55°C before cooling to room temperature. Thereafter, 4 mL of phenol was added, samples mixed for 30 minutes, centrifuged (5,000g, 10 minutes), and the DNA phase extracted in an equal volume of phenol/chloroform. After centrifugation the upper phase was removed and extracted in an equal volume of chloroform and the DNA precipitated with 2 vol of absolute ethanol. The precipitate was washed in 75% ethanol followed by absolute ethanol. After evaporation of the ethanol at room temperature the pellet was dissolved in 250 mL TE buffer (10 mmol/L Tris/HCl, 1 mmol/L EDTA, pH 8) and quantified by reading the absorbance at 260 nm (DU-50 Beckman spectrophotometer, High Wycombe, UK). Loading buffer (0.25% bromophenol blue, 0.25% xylene cyanol FF, 30% glycerol in water) containing RNAase A (1:100 dilution of 10 mg/mL) was added and 3 to 10 µg DNA electrophoresed in a 1.2% agarose gel at 40 V in 40 mmol/L Tris-acetate, 1 mmol/L EDTA.
View larger version (21K):
[in this window]
[in a new window]
| Fig 3.
Effect of neutrophil cell concentration on the early proapoptotic effect of TNF-. Human neutrophils were incubated at a cell concentration of 2.5 to 15 × 106/mL in the presence () or absence () of TNF- (12.5 ng/mL) for 6 hours at 37°C. Cytocentrifuge slides were then prepared for morphological assessment of apoptosis. Data represent the mean ± SEM of six observations in two separate experiments.
|
|
Propidium iodide (PI) staining was assessed according to Nicoletti et al,28 with the following modifications: 0.4 × 106 cells were suspended in 100 µL ice-cold 70% ethanol for 10 minutes, washed (×3) in phosphate-buffered saline (PBS) (4°C), and resuspended in 30 µL PBS and 30 µL RNAase (100 µg/mL). After gentle mixing 60 µL of propidium iodide (100 µg/mL in PBS) was added; the cells were incubated in the dark at room temperature for 15 minutes and after washing in PBS stored at 4°C before analysis using an EPICS Profile II (Coulter Electronics, Luton, UK). Mean fluorescence values were determined from a minimum of 5,000 cells within an analysis region corresponding to nonfragmented neutrophils.
Measurement of superoxide anion generation.
The release of superoxide anions was determined by means of the superoxide dismutase-inhibitable reduction of cytochrome C. Neutrophils (106 in 90 µL PBS containing CaCl2 and MgCl2 ) were placed in 2-mL polypropylene tubes containing 10 µL TNF- to give a final concentration of 0.05 to 50 ng/mL, or PBS (control). Each reaction was performed in quadruplicate. Samples were incubated in the presence or absence of TNF- for 30 minutes at 37°C in a shaking water bath before the addition of 750 µL cytochrome C (final concentration 1.2 mg/mL) to all samples and 50 µL of superoxide dismutase (20 µg/mL in PBS) to one sample in each quadruplicate. After a final 10-minute incubation with PBS or fMLP (100 nmol/L), samples were placed on ice and the optical density of the supernatants determined using a scanning spectrophotometer (Pye-Unicam 8700; Unicam Ltd, Cambridge, UK) measuring peak height at 550 nm with the paired dismutase-containing supernatants as reference. Superoxide release (nmoles/106 cells) was calculated using the extinction coefficient 21 × 103 (mol/L)-1.cm-1.
Effects of TNF- neutralizing antibodies, TNFR55 and TNFR75 blocking antibodies, and TNF- receptor-selective mutants on basal and TNF--stimulated neutrophil apoptosis.
Freshly isolated neutrophils were cultured as detailed above in either MDM plus 10% autologous serum alone (control), TNF- (12.5 ng/mL), mouse IgG1 antihuman TNF- neutralizing monoclonal antibody (MoAb) (1 µg/mL), or an identical concentration of TNF- preincubated for 90 minutes at 37°C with the neutralizing antibody. At 6 hours cells were harvested and apoptosis assessed as indicated above. To assess the effect of TNFR55 and TNFR75 blocking antibodies on the ability of TNF- to modulate the rate of neutrophil apoptosis, cells (5 × 106/mL) were preincubated for 30 minutes at 37°C in MDM containing 10% autologous serum in the presence or absence of 28 µg/mL of mouse IgG1 antihuman TNFR55, rat IgG2b antihuman TNFR75, or isotype-matched IL-2 (p55) receptor MoAb before a 6- or 20- hour incubation with TNF- (12.5 ng/mL) or buffer and morphological assessment of apoptosis. The saturating concentration of TNFR75 MoAb used was predetermined using a flow cytometry antibody titration assay29 and TNFR55 MoAb used at an identical concentration. In experiments using the TNFR55-selective mutants E146K and R32W-S86T or TNFR75-selective mutant D143F, freshly isolated neutrophils were incubated for 3 or 6 hours in the presence or absence of 0.01 to 100 ng/mL mutein or rhTNF- as previously detailed30 before morphological quantification of apoptosis or examination of DNA fragmentation.
Flow cytometric analysis of TNFR55 and TNFR75 expression.
Neutrophils were prepared, preincubated for 5 minutes with 1 µmol/L PAF or buffer, and then incubated (6.75 × 105 cells/150 µL MDM containing 10% autologous serum) in flexiwell plates at 37°C for 0 to 6 hours as detailed above. At the appropriate time points the cells were transferred to prechilled U-bottomed flexiwell plates, washed with ice-cold PBS containing 0.2% bovine serum albumin (BSA) and 0.1% sodium azide, and resuspended in 40 µL of a saturating concentration of mouse-antihuman TNFR55, TNFR75, or CD2 MoAb as a negative control (UCHT-1 clone, IgG1 ; SAPU, Carluke, UK). After a 30-minute period on ice the cells were washed twice and incubated with 40 µL fluorescein isothiocyanate (FITC)-conjugated goat-antimouse Ig (Dako, Buckinghamshire, UK; diluted 1 in 40 with PBS/BSA/azide buffer). After washing, samples were analyzed using an EPICS Profile II (Coulter Electronics) and mean fluorescence values from a minimum of 3,000 cells determined.
View larger version (13K):
[in this window]
[in a new window]
| Fig 4.
Concentration-response relationships for TNF--induced apoptosis, priming, and direct superoxide anion generation. Human neutrophils were prepared and incubated at 5 × 106/mL with 0 to 100 ng/mL TNF- for 6 hours for assessment of apoptosis (A) or at 107/mL with 0 to 100 ng/mL TNF- for 30 minutes before assessment of fMLP-stimulated (100 nmol/L, 10 minutes) (B) or direct superoxide anion generation (10 minutes) (C) using a cytochrome C reduction assay (see Materials and Methods). Values represent mean ± SEM of n = 3 separate experiments, each performed in triplicate. Where not shown, SEM values are less than 2% and fall within the symbols.
|
|
Enzyme-linked immunosorbent assay (ELISA) for TNF-.
Extracellular immunoreactive human TNF- was quantified using a modification of the double-ligand method as previously described.31 In brief, flat-bottomed 96-well microtiter plates (Immulon 1; Dynatech, Billinghurst, UK) were coated with 100 µL/well mouse-antihuman TNF- MoAb (2.5 µg/mL in coating buffer; Dynatech) for 3 hours at 37°C and then washed with PBS (pH 7.5), 0.05% Tween-20 (PBS-Tween-20). Microtiter plate nonspecific binding sites were blocked with Dynatech blocking buffer (30 minutes, 37°C). The plates were washed four times (PBS-Tween-20) and cell-free supernatants or TNF- standards (half-log dilutions of recombinant human [rh]TNF-, from 7.8 to 500 pg/mL) added in 100-µL aliquots in duplicate and incubated for 16 hours at 4°C. Plates were washed four times (PBS-Tween-20), followed by the addition of 100 µL/well rabbit polyclonal antihuman TNF- antibody (1 µg/mL in assay diluent; Dynatech) and the plates were incubated for 3 hours at room temperature. The plates were again washed, alkaline phosphatase-conjugated donkey-antirabbit IgG added, and following a further incubation of 3 hours at room temperature, p-nitrophenyl phosphate substrate added in 10% diethylamine (DEA) buffer. Plates were read at 410 nm in an ELISA reader.
Statistics.
All values are presented as the mean ± SEM of (n) number of independent experiments. The data were evaluated statistically using the paired or unpaired Students t-test: P values <.05 were considered to be statistically significant.
Materials.
Recombinant human TNF- (10 µg/mL in PBS) and GM-CSF (1 µg/mL in PBS) were purchased from Genzyme (Cambridge, MA) and stored at -70°C before use. Rat-antihuman TNFR75 MoAb and interleukin-2 (IL-2) receptor MoAb were also purchased from Genzyme (Cambridge, MA) and stored at 0.4 to 1 mg/mL in PBS (4°C). The mouse IgG1 antihuman TNF- neutralizing MoAb and mouse-antihuman TNFR55 and TNFR75 MoAbs were purchased from R & D Systems Europe (Abingdon, Oxon, UK). LTB4 , LPS (Escherichia coli 0111:B4,  -irradiated), InsP6 (di-potassium salt), fMLP, superoxide dismutase, cytochrome C, Dulbecco's PBS (with or without CaCl2 and MgCl2 ), p-nitrophenyl phosphate, proteinase K, trypan blue, and dextran-500 were all purchased from Sigma Chemical Co (Poole, Dorset, UK). fMLP was dissolved in sterile dimethyl sulfoxide (DMSO) at a stock concentration of 1 mmol/L and stored at -20°C. LTB4 was stored in ethanol at 100 µg/mL at -20°C. C18 PAF was obtained from Calbiochem-Novabiochem UK Ltd (Nottingham, UK) and dissolved in ethanol at a stock concentration of 10 mmol/L. Percoll was obtained from Pharmacia Biotech (St Albans, Hertfordshire, UK). MDM was obtained from Life Technologies (Paisley, Scotland, UK). Alkaline phosphatase-conjugated donkey-antirabbit IgG was purchased from Stratech Scientific Ltd (Luton, Bedfordshire, UK). All other reagents were obtained from Sigma Chemical Co or Merck Ltd and were of the highest purity available.
| |
RESULTS |
Effect of TNF- on the rate of neutrophil apoptosis in vitro.
In agreement with previous studies,21 coincubation of human neutrophils with 25 ng/mL TNF- for 20 hours caused a small but significant inhibition of neutrophil apoptosis (Fig 1A and C). This effect concurs with our previous observations that many other agents that prime or activate human neutrophils either delay (GM-CSF, Fig 1C, C5a, LPS,16 InsP6 ,32 and LTB4 , results not shown), or have no effect on (fMLP and PAF, results not shown), the rate of constitutive apoptosis when assessed at this time point. However, when cytospins were prepared at earlier times (3 to 6 hours) when the basal rate of apoptosis was still low, TNF- caused a significant increase in the number of apoptotic cells present (Fig 1A). This early proapoptotic effect of TNF- was rapid (observed in all experiments by 2 hours, Fig 1B), maximal in terms of the ratio of apoptotic to nonapoptotic cells by 6 hours (Fig 1B), and was not observed with any of the other priming/activating agents tested at 6 hours (50 U/mL GM-CSF [Fig 1C], 1 and 100 nmol/L fMLP, 1 µmol/L PAF, 100 µmol/L InsP6 , or 100 µmol/L LTB4 , data not shown). Accurate quantification of the effects of such agents (including TNF-) beyond 24 hours was not possible because of the development of secondary necrosis at these times.
View larger version (21K):
[in this window]
[in a new window]
| Fig 5.
Loss of the early proapoptotic effect of TNF- in human neutrophils after delayed addition of TNF- or pretreatment with PAF. (A) To assess the effect of delayed addition of TNF-, human neutrophils were incubated at 5 × 106/mL in the absence () or presence of 12.5 ng/mL TNF- added either at the beginning of the incubation period () or after a delay of 6 hours (). The extent of apoptosis was then assessed morphologically at the time points indicated. All data values represent the mean ± SEM of n = 3 separate experiments, each performed in triplicate (*P < .05 compared with time-matched controls). Where not shown, SEM values are less than 2% of means. (B) Human neutrophils (5 × 106/mL) were incubated in MDM containing 10% autologous serum in the presence or absence of PAF (1 µmol/L) for 5 minutes before being placed in 96-well flexiwell plates for a 6-hour incubation with 12.5 ng/mL TNF- or buffer. Apoptosis was then determined on cytocentrifuge preparations using standard morphological criteria. Values represent mean ± SEM of three separate experiments, each performed in triplicate (*P < .05 compared with controls).
|
|
The induction of apoptosis by TNF- at early time points was confirmed by DNA electrophoresis, which showed a typical ladder pattern in TNF--treated neutrophils indicative of endonuclease-dependent internucleosomal cleavage (see Fig 8), and by PI staining, which revealed an increase in the percentage of cells with hypodiploid DNA content in TNF--treated cells (Fig 2B) (control 6 hours, 4.4% ± 0.3%; 12.5 ng/mL TNF- 6 hours, 18.2% ± 0.1%; P < .05, n = 3). These latter values exactly match the extent of apoptosis assessed by morphological criteria (Fig 2A) (control 6 hours, 4.6% ± 0.2%; 12.5 ng/mL TNF- 6 hours, 17.2% ± 1.4%; P < .05, n = 3). The late inhibitory effect of TNF- on neutrophil apoptosis (20 hours) was also confirmed using this technique (Fig 2B) (percent low PI stained cells: control 20 hours, 55.9% ± 0.3%; 12.5 ng/mL TNF- 20 hours, 46.9% ± 1.5%; P < .05, n = 3).
View larger version (22K):
[in this window]
[in a new window]
View larger version (72K):
[in this window]
[in a new window]
| Fig 8.
Effect of TNF- receptor selective mutants on human neutrophil apoptosis. (A) Human neutrophils were incubated with 0.01 to 100 ng/mL of wildtype TNF- (wtTNF-, ), the TNFR55-selective mutants R32WS86T ( ) or E146K ( ), and the TNFR75 selective mutant D143F ( ). Apoptosis was assessed morphologically after 3 hours. Data represent mean ± SEM of three experiments each performed in triplicate. (B) Neutrophils were incubated under identical conditions with 0 to 100 ng/mL wild-type TNF-, 10 to 100 ng/mL E146K, or 10 to 100 ng/mL D143F. Thereafter the cells were pelletted and incubated overnight in sodium acetate/EDTA/proteinase K/1% SDS before phenol/chloroform DNA extraction as detailed in Materials and Methods. After precipitation with ethanol, 10 µg of DNA was loaded per lane and separated on a 1.2% agarose gel.
|
|
The specificity of action of TNF- was shown in experiments where the proapoptotic effect of TNF- was completely abolished by preincubation with mouse-antihuman TNF- neutralizing antibody (percent apoptosis at 6 hours: control, 6.7% ± 0.6%; 25 ng/mL TNF-, 17.3% ± 1.4%; TNF- antibody, 6.2% ± 0.8%; TNF- + TNF- antibody, 6.0 ± 0.7%; n = 3). In addition, TNF- did not affect neutrophil viability (trypan blue exclusion) or recovery rates (data not shown), excluding the possibility that the increased rates of early apoptosis observed reflected either TNF--induced adhesion of nonapoptotic cells33 or a TNF--induced switch between necrosis and apoptosis as seen in human leukemic cells treated with high concentrations of alkylating agents.34 Examination of the influence of neutrophil cell concentration on the action of TNF- at 6 hours showed that the proapoptotic effect was most marked at 2.5 to 5 × 106 cells/mL (Fig 3). A cell concentration of 5 × 106/mL was selected for use in subsequent studies as this was the optimal cell density for preparation and quantification of cytospins. Assay of the TNF- concentration present in cell supernatants at 0, 6, and 20 hours showed no evidence of spontaneous TNF- production35 or decline in the level of exogenously added TNF- (Table 1).
View larger version (31K):
[in this window]
[in a new window]
| Fig 6.
Time-course for TNFR55 and TNFR75 expression in the presence and absence of PAF. (A) Flow cytometric analysis of CD2 (negative control), TNFR55, and TNFR75 receptor expression in freshly isolated neutrophils. Histograms represent profiles of cell count against log fluorescence and are representative examples from nine separate experiments. (B and C) Human neutrophils (5 × 106/mL) were incubated in MDM containing 10% autologous serum in the presence or absence of PAF (1 µmol/L) for 5 minutes before incubation for 1 to 6 hours in flexiwell plates at 37°C. At these time points TNFR55 (B) and TNFR75 (C) expression was quantified by flow cytometry as detailed in Materials and Methods. Data represent percent of specific receptor expression values obtained in freshly isolated cells with each point being the mean ± SEM of three separate experiments, each performed in triplicate.
|
|
Relationship between TNF--induced apoptosis and priming.
The potential physiological relevance of the proapoptotic effect of TNF- was assessed initially by comparing the concentration-dependency of this response with the ability of TNF- to directly stimulate superoxide anion generation in neutrophils and to prime fMLP (100 nmol/L)-stimulated respiratory burst activity. Figure 4 shows the very similar concentration-response relationships for all three effects with an EC50 for TNF--induced apoptosis of 2.8 ng/mL.
To assess whether the induction of apoptosis by TNF- was itself influenced by neutrophil priming, cells were either preincubated in flexiwell plates for 6 hours or pretreated with 1 µmol/L PAF for 5 minutes before the addition of TNF-. Priming with PAF resulted in a dramatic upregulation of fMLP-stimulated superoxide anion release (superoxide anion release, nmol/106 cells/10 min, control 0.9 ± 0.1, 100 nmol/L fMLP 3.4 ± 0.4, 1 µmol/L PAF 0.8 ± 0.1, 1 µmol/L PAF + 100 nmol/L fMLP 33.1 ± 2.0, n = 3) with the adhesion-based model also converting TNF- into a full secretagogue agonist33,36 (and data not shown). As shown in Fig 5, both strategies abolished the proapoptotic effect of TNF-, although by contrast, the late inhibitory effect of TNF- on apoptosis at 20 hours appeared to be enhanced when TNF- addition was delayed (Fig 5A). Flow cytometric analysis of TNFR55 and TNFR75 expression in freshly isolated neutrophils demonstrated a single population of TNFR55 and TNFR75 positive cells (Fig 6A) with mean fluorescence values of 4.06 ± 0.26 and 5.40 ± 0.53, respectively (CD2 control values 1.50 ± 0.10, n = 9). Incubation of neutrophils in flexiwell plates under the identical conditions described above resulted in a time-dependent decrease in both TNFR55 and TNFR75 expression (Fig 6B and C); however, preincubation of neutrophils with 1 µmol/L PAF for 5 minutes, which completely abolished the ability of TNF- to induce apoptosis, had no effect on either TNFR55 or TNFR75 expression (Fig 6B and C).
TNFR55 and TNFR75 dependency of TNF--stimulated neutrophil apoptosis.
The involvement of TNFR55 and TNFR75 in mediating the early proapoptotic effect of TNF- was examined using TNF- receptor subtype selective blocking MoAbs and agonistic mutants. In preliminary experiments the dominant role of TNFR55 in mediating TNF--induced priming of superoxide anion generation in neutrophils in suspension was confirmed37,38 in that the TNFR55 MoAb completely blocked TNF--induced priming of fMLP-stimulated superoxide anion generation whereas the TNFR75 MoAb had no effect on this response (data not shown). In contrast, however, an identical 30-minute preincubation of neutrophils with either TNFR55 or TNFR75 MoAb completely abrogated the proapoptotic effect of TNF- (Fig 7). Neither the antibodies themselves (Fig 7) nor isotype-matched control MoAbs (data not shown) affected basal or, in the latter case, TNF--stimulated apoptosis. Of interest, the TNFR75 MoAb did not influence the late inhibitory effect of TNF- on apoptosis observed at 20 hours (percent apoptosis at 20 hours: control, 58.7% ± 1.2%; TNF-, 38.7% ± 3.4%; TNFR75 MoAb, 51.4% ± 1.6%; TNF- + TNFR75 MoAb, 32.4% ± 1.0%). These data indicate that the TNF--induced priming and late inhibitory effect on apoptosis are mediated via TNFR55, but the early proapoptotic effect is dependent on both TNFR55 and TNFR75 activation.
View larger version (17K):
[in this window]
[in a new window]
| Fig 7.
Effect of TNFR55 and TNFR75 blocking antibodies on TNF--induced apoptosis in human neutrophils. Human neutrophils (5 × 106/mL) were preincubated with antihuman TNFR55 or TNFR75 MoAbs for 30 minutes at 37°C before a 6-hour incubation in the presence or absence of 12.5 ng/mL TNF-. The extent of apoptosis was then assessed by morphological examination of cytocentrifuge preparations. Data represent mean ± SEM of three separate experiments each performed in triplicate. Where not shown, SEM values are less than 5% of means.
|
|
Complementary experiments were performed using the TNFR55-selective TNF- agonistic mutants E146K and R32W-S86T and the TNFR75-selective mutant D143F. The former peptides have a 3,300- and 5,000-fold lower affinity for the TNFR75 receptor with only marginal (2- and 2.2-fold) reduction in TNFR55 affinity whereas the TNFR75 ligand D143F displays a 30-fold reduced affinity to TNFR75 and no binding to TNFR55.25,26 Figure 8 shows the ability of both TNFR55 mutants to induce morphological and DNA ladder evidence of neutrophil apoptosis, albeit with a lower potency than recombinant human TNF- (EC50 values, ng/mL: wild-type TNF-, 5.0; E146K, 82.7; R32W-S86T, 69.5; both P < .01 compared with TNF-). The induction of apoptosis by E146K and R32W-S86T was also inhibited completely by preincubation with TNFR55 MoAb (Fig 9). The TNFR75 selective agonist D143F, which causes a prompt induction of GM-CSF production in TNFR75 transfected PC12 cells that lack TNFR55 expression,30 did not induce apoptosis even at a concentration of 100 ng/mL (Fig 8). These data imply that TNFR75 facilitates the ability of TNFR55 to induce apoptosis in human neutrophils.
View larger version (17K):
[in this window]
[in a new window]
| Fig 9.
Effect of TNFR55 blocking antibodies on TNFR55-selective mutant-induced neutrophil apoptosis. Human neutrophils (5 × 106/mL) were preincubated in the presence ( ) or absence () of antihuman TNFR55 MoAbs before stimulation with medium alone (control), 12.5 ng/mL TNF-, or 100 ng/mL of the TNFR55 selective mutant proteins E146K or RWS86T for 6 hours. The extent of apoptosis was assessed morphologically. Data represent mean ± SEM of three separate experiments, each performed in triplicate.
|
|
| |
DISCUSSION |
We have shown that TNF- has a unique and bimodal effect on the rate of apoptosis in human neutrophils and have provided an explanation for the previous divergent reports that TNF- either inhibits,21 has no effect on,39 or induces apoptosis in neutrophils.40,41 Our data also reveal that the early proapoptotic effect of TNF-, in contrast to its priming effect observed in neutrophils in suspension, or indeed the apoptotic effect of TNF- observed in nonhematopoietic cells, is critically dependent on engagement of both TNFR55 and TNFR75 receptors.
Neutrophils undergo constitutive apoptosis when aged in vitro,1-7 yet appear highly resistant to any attempt to accelerate this process using physiological agonists. Indeed, we have shown that even stimuli that are potent inducers of apoptosis in other cell types (eg, corticosteroids, elevation of intracellular Ca2+ and hypoxia) all inhibit rather than augment the rate of apoptosis in these cells.17,42,43 The only other physiological agonist reported to induce neutrophil apoptosis is IL-644; however, this effect was small, has not been confirmed by at least two other groups,40,45 and the extent of apoptosis recorded (10% compared to 15% in the presence of IL-6 at 24 hours) is very different than that reported in all other comparable studies. Hence, TNF- appears to have the unique ability not shared by other neutrophil priming and activating agents to induce neutrophil apoptosis.
The effectiveness of the TNFR55-selective mutants E146K and R32W-S86T to induce apoptosis in human neutrophils implies that TNFR75 functions to facilitate a death signal primarily initiated via TNFR55. This conclusion is supported by experiments using rat neutrophils where induction of apoptosis occurs with human TNF- that does not interact with the mouse TNFR75 receptor.41 Involvement of TNFR75 in TNF--induced death appears to be restricted to hematopoietic cells and was initially thought to reflect the ability of TNFR75 to present TNF- to TNFR55 via a "ligand passing" effect.46 However data in PC60 T-cell hybridoma cells, where coexpression of high levels of TNFR75 in addition to low levels of TNFR55 is likewise required to observe TNF--stimulated apoptosis, have excluded such a mechanism.47 The involvement of TNFR75-derived intracellular signals in mediating the death effect of TNF- is supported by the recent demonstration that TNF- can induce T-cell receptor-induced apoptosis in p55-/- mice, indicating that under certain circumstances TNFR75 can function alone to induce apoptotic cell death,18 and similar conclusions have been reached in HeLa cells using TNFR75 selective antibodies.48 The precise mechanism whereby TNFR75 initiates apoptosis or permits TNFR55-induced death remains uncertain, not least because this receptor subtype has a relatively short cytoplasmic domain with no intrinsic kinase activity or death domain sequence (as found in TNFR55 and Fas).23 However, the discovery of a TNFR75-associated kinase that phosphorylates both TNF- receptors provides a potential mechanism whereby TNFR75 could facilitate TNFR55 intracellularly.49
The observation that only a proportion of neutrophils undergo apoptosis in response to TNF- is of particular interest, not least because there was no detectable decline in TNF- levels over the 20-hour incubation period studied. There is no evidence to support heterogeneous TNF- receptor expression in neutrophils because TNF- stimulates uniform CD18-dependent latex bead binding in nearly 100% of neutrophils50 and flow cytometric analysis demonstrates a single population of TNFR55 and TNFR75 positive cells (Fig 6A). However, heterogeneous neutrophil responses to other stimuli such as LPS augmentation of fMLP-induced Ca2+ transients are well documented51 and other factors such as cell maturity may be important in dictating the susceptibility of individual cells to apoptosis. Our data have also shown a discrete TNFR55-mediated survival effect of TNF- which is evident at later incubation times and is particularly obvious when the early proapoptotic effect is abolished (Fig 5A); this effect is likely to limit the extent of apoptosis occurring at earlier times. Furthermore, TNF- induces substantial TNFR55 and TNFR75 loss under our assay conditions (S.A.D., J.M., and I.D., unpublished observations), which again may further curtail the proapoptotic effect of TNF-.52 Such a proposal would agree with the findings of Tsuchida et al,41 who have shown a correlation in rat neutrophils between TNF- receptor numbers and TNF--induced apoptosis.
The loss of the proapoptotic effect of TNF- when cells were cultured for 6 hours before cytokine addition may well reflect the major decrease in TNFR55 and TNFR75 expression that occurs over this period (Fig 6B and C), but this mechanism does not appear to account for the similar effect observed with PAF where no change in TNFR55 or TNFR75 expression was observed. Although a previous study has reported that PAF induces a 50% decline in total TNFR expression using 125I-TNF- binding, this effect was obtained after a 2-hour rather than a 5-minute incubation period and used PAF at a concentration of 100 µmol/L.33 However, it is possible that PAF influences receptor coupling rather than expression and/or that TNF- is sensitive to PAF-induced protease release. TNF- has also been shown to enhance thrombospondin-mediated phagocytosis of apoptotic neutrophils by monocyte-derived macrophages,53 suggesting a potentially synergistic or dual mechanism whereby TNF- may enhance the removal of neutrophils from an inflamed site by accelerating apoptosis and facilitating clearance.
These data indicate that in addition to its ability to upregulate many aspects of neutrophil function,54,55 TNF- also has the capacity, unique among other priming/activating agents, to promote neutrophil apoptosis. Although the neutrophil is a short-lived cell, it is interesting to speculate that depending on the balance of inflammatory mediators present at an inflamed site, there is clearly the potential for neutrophil function and longevity to be either upregulated or downregulated. This effect of TNF- may explain at least in part certain in vivo findings; for example, how the administration of anti-TNF- antibodies results in delayed resolution of the neutrophilic alveolitis induced by Legionella pneumophila,56 and why pneumococcus (one of the most potent inducers of alveolar macrophage TNF- production57 ) causes a form of pneumonia that usually resolves with minimal residual organ damage.58 In view of recent observations that genetic variations in the TNF- gene promotor region are associated with differences in constitutive and inducible concentrations of TNF- and that this alters the clinical course of malaria and tuberculosis infection,59 it is also tempting to speculate that similar influences may also have a bearing on neutrophil influx and clearance at sites of inflammation. The recognition that neutrophil apoptosis can be stimulated by TNF- and that the priming and apoptotic effects of this cytokine can be dissociated may help in the design of more rational and/or selective anti-inflammatory therapy.
| |
FOOTNOTES |
Submitted October 15, 1996;
accepted May 27, 1997.
Supported by The Wellcome Trust, MRC (UK) and the National Health and Medical Research Council of Australia. E.R.C. is a Wellcome Trust Senior Research Fellow in Clinical Science and A.M.C. and S.A.D. are Medical Research Council Clinical Training Fellows.
Address reprint requests to Edwin R. Chilvers, MD, PhD, Respiratory Medicine Unit, Department of Medicine (RIE), University of Edinburgh, Rayne Laboratory, Medical School, Teviot Place, Edinburgh EH8 9AG, UK.
The publication costs of this article were defrayed in part by page
charge payment. This article must therefore be hearly marked
``advertisment'' in accordance with 18 U.S.C. section 1734 solely to
indicate this fact.
| |
ACKNOWLEDGMENT |
We are grateful to D. May for secretarial assistance. The TNFR55 and TNFR75 receptor-selective TNF- mutants E146K, R32W-S86T, and D143F were kindly provided by Prof Walter Fiers (University of Ghent, Ghent, Belgium).
| |
REFERENCES |
1.
Savill JS,
Wyllie AH,
Henson JE,
Walport MJ,
Henson PM,
Haslett C:
Macrophage phagocytosis of ageing neutrophils in inflammation. Programmed cell death in the neutrophil leads to recognition by macrophages.
J Clin Invest
83:865,
1989
2.
Savill JS,
Henson PM,
Haslett C:
Phagocytosis of aged human neutrophils by macrophages is mediated by a novel "charge sensitive" recognition mechanism.
J Clin Invest
84:1518,
1989
3.
Haslett C,
Savill JS,
Meagher L:
The neutrophil.
Curr Opin Immunol
2:10,
1989[Medline]
[Order article via Infotrieve]
4.
Savill JS,
Dransfield I,
Hogg N,
Haslett C:
Macrophage recognition of `senescent self'; the vitronectin receptor mediates phagocytosis of cells undergoing apoptosis.
Nature
342:170,
1990
5.
Savill JS,
Hogg N,
Haslett C:
Thrombospondin co-operates with CD36 and the vitronectin receptor in macrophage recognition of aged neutrophils.
J Clin Invest
90:1513,
1992
6.
Haslett C,
Savill JS,
Whyte MKB,
Stern M,
Dransfield I,
Meagher LC:
Granulocyte apoptosis and the control of inflammation.
Phil Trans R Soc London B
345:327,
1994[Medline]
[Order article via Infotrieve]
7.
Whyte MKB,
Meagher LC,
MacDermot J,
Haslett C:
Impairment of function in ageing neutrophils is associated with apoptosis.
J Immunol
150:5123,
1993
8.
Meagher LC,
Savill JS,
Baker A,
Fuller R,
Haslett C:
Phagocytosis of apoptotic neutrophils does not induce macrophage release of thromboxane B2 .
J Leukoc Biol
52:269,
1992[Abstract]
9.
Cox G,
Crossley J,
Xing Z:
Macrophage engulfment of apoptotic neutrophils contributes to the resolution of acute pulmonary inflammation in vivo.
Am J Respir Cell Mol Biol
12:232,
1995[Abstract]
10.
Grigg JM,
Savill JS,
Sarraf C,
Haslett C,
Silverman M:
Neutrophil apoptosis and clearance from neonatal lungs.
Lancet
338:720,
1991[Medline]
[Order article via Infotrieve]
11.
Savill JS,
Smith J,
Ren Y,
Sarraf C,
Abbott F,
Rees AJ:
Glomerular mesangial cells and inflammatory macrophages ingest neutrophils undergoing apoptosis.
Kidney Int
42:924,
1992[Medline]
[Order article via Infotrieve]
12.
Begley CG,
Lopez AF,
Nicola NA:
Purified colony-stimulating factors enhance the survival of human neutrophils and eosinophils in vitro: A rapid and sensitive microassay for colony-stimulating factors.
Blood
68:162,
1986[Abstract/Free Full Text]
13.
Ichinose Y,
Hara N,
Ohtu M,
Aso H,
Chikama H,
Kawasaki M,
Kubota I,
Shimizu T,
Yagawa K:
Recombinant granulocyte colony-stimulating factor and lipopolysaccharide maintain the phenotype of and superoxide anion generation by neutrophils.
Infect Immun
58:1647,
1990[Abstract/Free Full Text]
14.
Brach MA,
de Vos S,
Gruss H-J,
Herrman F:
Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death.
Blood
80:2920,
1992[Abstract/Free Full Text]
15.
Cox G,
Gauldie J,
Jordana M:
Bronchial epithelial cell-derived cytokines (G-CSF and GM-CSF ) promote the survival of peripheral blood neutrophils in vitro.
Am J Respir Mol Cell Biol
7:507,
1992
16.
Lee A,
Whyte MKB,
Haslett C:
Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators.
J Leukoc Biol
54:283,
1993[Abstract]
17.
Hannah S,
Mecklenburgh K,
Rahman I,
Bellingan GJ,
Greening A,
Haslett C,
Chilvers ER:
Hypoxia prolongs neutrophil survival in vitro.
FEBS Lett
372:233,
1995[Medline]
[Order article via Infotrieve]
18.
Zheng L,
Fisher G,
Miller RE,
Peschon J,
Lynch DH,
Lenardo MJ:
Induction of apoptosis in mature T cells by tumour necrosis factor.
Nature
377:348,
1995[Medline]
[Order article via Infotrieve]
19.
Obeid LM,
Linardic CM,
Karolak LA,
Hannun YA:
Programmed cell death induced by ceramide.
Science
259:1769,
1993[Abstract/Free Full Text]
20.
Mangan DF,
Wahl SM:
Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines.
J Immunol
147:3408,
1991[Abstract]
21.
Colotta F,
Re F,
Polentarutti N,
Sozzani S,
Mantovani A:
Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products.
Blood
80:2012,
1992[Abstract/Free Full Text]
22.
Genestier L,
Bonnefoy-Berard N,
Rouault J-P,
Flacher M,
Revillard J-P:
Tumour necrosis factor- up-regulates Bcl-2 expression and decreases calcium-dependent apoptosis in human B cell lines.
Int Immunol
7:533,
1995[Abstract/Free Full Text]
23.
Tartaglia LA,
Ayres TM,
Wong GHW,
Goeddel DV:
A novel domain within the 55kd TNF receptor signals cell death.
Cell
74:845,
1993[Medline]
[Order article via Infotrieve]
24.
Van Ostade X,
Vandenabeele P,
Everaerdt B,
Loetscher H,
Brockhaus M,
Lesslauer W,
Tavernier J,
Brouckaert P,
Fiers W:
Human TNF mutants with selective activity on the p55 receptor.
Nature
361:266,
1993[Medline]
[Order article via Infotrieve]
25.
Van Ostade X,
Vandenabeele P,
Tavernier J,
Fiers W:
Human tumour necrosis factor mutants with preferential binding to and activity on either the R55 or R75 receptor.
Eur J Biochem
220:771,
1994[Medline]
[Order article via Infotrieve]
26.
Loetscher H,
Stueber D,
Banner D,
Mackay F,
Lesslauer W:
Human tumor necrosis factor (TNF) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors.
J Biol Chem
268:26350,
1993[Abstract/Free Full Text]
27.
Haslett C,
Guthrie LA,
Kopaniak MM,
Johnstone RB,
Henson PM:
Modulation of multiple neutrophil function by preparative methods or trace concentrations of bacterial lipopolysaccharide.
Am J Pathol
119:101,
1985[Abstract]
28.
Nicoletti I,
Migliorati G,
Oagliacci MC,
Grignani F,
Riccardi C:
A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry.
J Immunol Meth
139:271,
1991[Medline]
[Order article via Infotrieve]
29.
Qu J,
Condliffe AM,
Lawson M,
Plevin RJ,
Riemersma RA,
Barclay GR,
McClelland DB,
Chilvers ER:
Lack of effect of recombinant platelet-derived growth factor on human neutrophil function.
J Immunol
154:4133,
1995[Abstract]
30.
Barbara JAJ,
Smith WB,
Gamble JR,
Van Ostade X,
Vandenabeele P,
Tavernier J,
Fiers W,
Vadas MA,
Lopez AF:
Dissociation of TNF- cytotoxic and proinflammatory activities by p55 receptor- and p75 receptor-selective TNF- mutants.
EMBO J
13:843,
1994[Medline]
[Order article via Infotrieve]
31.
Van Otteren GM,
Standiford TJ,
Kunkel SL,
Danforth JM,
Strieter RM:
Alterations of ambient oxygen tension modulate the expression of tumor necrosis factor and macrophage inflammatory protein-1 alpha from murine alveolar macrophages.
Am J Respir Cell Mol Biol
13:399,
1995[Abstract]
32.
Eggleton P,
Penhallow J,
Crawford N:
Priming action of inositol hexakisphosphate (InsP6 ) on the stimulated respiratory burst in human neutrophils.
Biochim Biophys Acta
1094:309,
1991[Medline]
[Order article via Infotrieve]
33.
Schleiffenbaum B,
Fehr J:
The tumour necrosis factor receptor and human neutrophil function.
J Clin Invest
86:184,
1990
34.
Lennon SV,
Martin SJ,
Cotter TG:
Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli.
Cell Prolif
24:203,
1991[Medline]
[Order article via Infotrieve]
35.
Xing Z,
Kirpalani H,
Torry D,
Jordana M,
Gauldie J:
Polymorphonuclear leukocytes as a significant source of tumor necrosis factor- in endotoxin-challenged lung tissue.
Am J Pathol
143:1009,
1993[Abstract]
36.
Nathan C,
Sanchez E:
Tumor necrosis factor and CD11/CD18 ( 2 ) integrins act synergistically to lower cAMP in human neutrophils.
J Cell Biol
111:2171,
1990[Abstract/Free Full Text]
37.
Abe Y,
Osuka Y,
Nadata T,
Kashu Y,
Kimura S:
The functional role of 55- and 75-kDa tumour necrosis factor receptors in human polymorphonuclear cells in vitro.
Cytokine
7:39,
1995[Medline]
[Order article via Infotrieve]
38.
Menegazzi R,
Cramer R,
Patriarca P,
Scheurich P,
Dri P:
Evidence that tumor necrosis factor- (TNF )-induced activation of neutrophil respiratory burst on biologic surfaces is mediated by the p55 TNF receptor.
Blood
84:287,
1994[Abstract/Free Full Text]
39. Kwon MS, Heinz H, Abid H, Leibold W: Differential influences of recombinant TNF and recombinant IFN- on purified polymorpholeukocytes in vitro, in Bonavida B, Gifford GE, Kircher J, Old LJ (eds): Tumour Necrosis Factor/Cachectin and Related Cytokines. Basal, Switzerland, Karger, 1988, p 87
40.
Takeda Y,
Watanabe H,
Yonehara S,
Yamashita T,
Saito S,
Sendo F:
Rapid acceleration of neutrophil apoptosis by tumour necrosis factor-.
Int Immunol
5:691,
1993[Abstract/Free Full Text]
41.
Tsuchida H,
Takeda Y,
Takei H,
Shinzawa H,
Takahashi T,
Sendo F:
In vivo regulation of rat neutrophil apoptosis occurring spontaneously or induced with TNF- or cyclohexamide.
J Immunol
154:2403,
1995[Abstract]
42.
Meagher LC,
Cousin JM,
Seckl JR,
Haslett C:
Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes.
J Immunol
156:4422,
1996[Abstract]
43.
Whyte MKB,
Meagher LC,
Hardwick S,
Savill J,
Haslett C:
Transient elevations of cytosolic free calcium retard subsequent apoptosis in neutrophils in vitro.
J Clin Invest
92:446,
1993
44.
Afford SC,
Pongracz J,
Stockley RA,
Crocker J,
Burnett D:
The induction by human interleukin-6 of apoptosis in the promonocytic cell line U937 and human neutrophils.
J Biol Chem
267:21612,
1992[Abstract/Free Full Text]
45.
Biffl WL,
Moore EE,
Moore FA,
Barnett CC:
Interleukin-6 suppression of neutrophil apoptosis is neutrophil concentration dependent.
J Leukoc Biol
58:582,
1995[Abstract]
46.
Tartaglia LA,
Pennica D,
Goeddel DV:
Ligand passing: The 75-kDa tumor necrosis factor (TNF ) receptor recruits TNF for signaling by the 55-kDa receptor.
J Biol Chem
268:18542,
1993[Abstract/Free Full Text]
47.
Vandenabeele P,
Declercq W,
Vanhaesebroeck B,
Grooten J,
Fiers W:
Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells.
J Immunol
154:2904,
1995[Abstract]
48.
Bigda J,
Beletsky I,
Brakebusch C,
Varfolomeeu Y,
Engelmann H,
Bigda J,
Holfmann H,
Wallach D:
Dual role of the p75 tumor necrosis factor (TNF ) receptor in TNF cytotoxicity.
J Exp Med
180:445,
1994[Abstract/Free Full Text]
49.
Dornay BG,
Reddy SAG,
Aggarwal BB:
Physical and functional association of a serine-threonine protein kinase to the cytoplasmic domain of the p80 form of the human tumor necrosis factor receptor in human histiocytic lymphoma V-937 cells.
J Biol Chem
269:19687,
1994[Abstract/Free Full Text]
50.
Condliffe AM,
Chilvers ER,
Haslett C,
Dransfield I:
Priming differentially regulates neutrophil adhesion molecule expression/function.
Immunology
89:105,
1996[Medline]
[Order article via Infotrieve]
51.
Yee J,
Christou NV:
Neutrophil priming by lipopolysaccharide involves heterogeneity in calcium-mediated signal transduction.
J Immunol
150:1988,
1988[Abstract]
52.
Higuchi M,
Aggarwal BB:
TNF induces internalization of the p60 receptor and shedding of the p80 receptor.
J Immunol
152:3550,
1994[Abstract]
53.
Ren Y,
Savill JS:
Proinflammatory cytokines potentiate thrombospondin-mediated phagocytosis of neutrophils undergoing apoptosis.
J Immunol
154:2366,
1995[Abstract]
54.
Kishimoto TK,
Jutila MA,
Berg EL,
Butcher EC:
Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors.
Science
245:1238,
1989[Abstract/Free Full Text]
55.
Griffin JD,
Spertini O,
Ernst TJ,
Belvin MP,
Levine HB,
Kanakura Y,
Tedder T:
Granulocyte-macrophage colony stimulating factor and other cytokines regulate surface expression of the leukocyte adhesion molecule-1 on human neutrophils, monocytes and their precursors.
J Immunol
145:576,
1990[Abstract]
56. Skerrett SJ, Bagby GJ, Nelson S: Antibody to tumour necrosis factor impairs pulmonary clearance of Legionella pneumophila. Am J Respir Crit Care Med 149:A871, 1994 (abstr)
57.
Simpson SQ,
Singh R,
Bice DE:
Heat-killed pneumococci and pneumococcal capsular polysaccharides stimulate tumor necrosis factor- production of murine macrophages.
Am J Respir Cell Mol Biol
10:284,
1994[Abstract]
58.
Robertson OH,
Uhley CG:
Changes occurring in the macrophage system of the lungs in pneumococcus lobar pneumonia.
J Clin Invest
15:115,
1938
59.
Tracey KJ:
TNF and Mae West or: Death from too much of a good thing.
Lancet
345:75,
1995[Medline]
[Order article via Infotrieve]
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
S. Michlewska, I. Dransfield, I. L. Megson, and A. G. Rossi
Macrophage phagocytosis of apoptotic neutrophils is critically regulated by the opposing actions of pro-inflammatory and anti-inflammatory agents: key role for TNF-{alpha}
FASEB J,
March 1, 2009;
23(3):
844 - 854.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D G Downey, S C Bell, and J S Elborn
Neutrophils in cystic fibrosis
Thorax,
January 1, 2009;
64(1):
81 - 88.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Elbim, V. Monceaux, Y. M. Mueller, M. G. Lewis, S. Francois, O. Diop, K. Akarid, B. Hurtrel, M.-A. Gougerot-Pocidalo, Y. Levy, et al.
Early Divergence in Neutrophil Apoptosis between Pathogenic and Nonpathogenic Simian Immunodeficiency Virus Infections of Nonhuman Primates
J. Immunol.,
December 15, 2008;
181(12):
8613 - 8623.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. P. Holt, L. Cheng, and C. Ju
Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury
J. Leukoc. Biol.,
December 1, 2008;
84(6):
1410 - 1421.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. I. Hirsh and W. G. Junger
Roles of Heat Shock Proteins and {gamma}{delta}T Cells in Inflammation
Am. J. Respir. Cell Mol. Biol.,
November 1, 2008;
39(5):
509 - 513.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Himpe, C. Degaillier, A. Coppens, and R. Kooijman
Insulin-like growth factor-1 delays Fas-mediated apoptosis in human neutrophils through the phosphatidylinositol-3 kinase pathway
J. Endocrinol.,
October 1, 2008;
199(1):
69 - 80.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D J McKeon, A M Condliffe, A S Cowburn, K C Cadwallader, N Farahi, D Bilton, and E R Chilvers
Prolonged survival of neutrophils from patients with {Delta}F508 CFTR mutations
Thorax,
July 1, 2008;
63(7):
660 - 661.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Cross, R. J. Moots, and S. W. Edwards
The dual effects of TNF{alpha} on neutrophil apoptosis are mediated via differential effects on expression of Mcl-1 and Bfl-1
Blood,
January 15, 2008;
111(2):
878 - 884.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Yoshimura and M. Takahashi
IFN-{gamma}-Mediated Survival Enables Human Neutrophils to Produce MCP-1/CCL2 in Response to Activation by TLR Ligands
J. Immunol.,
August 1, 2007;
179(3):
1942 - 1949.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Rae, S. Langa, S. J. Tucker, and D. J. MacEwan
Elevated NF-{kappa}B responses and FLIP levels in leukemic but not normal lymphocytes: reduction by salicylate allows TNF-induced apoptosis
PNAS,
July 31, 2007;
104(31):
12790 - 12795.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. R. Dover, P. W. F. Hadoke, L. J. Macdonald, E. Miller, D. E. Newby, and B. R. Walker
Intravascular Glucocorticoid Metabolism during Inflammation and Injury in Mice
Endocrinology,
January 1, 2007;
148(1):
166 - 172.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. E. Kilpatrick, S. Sun, D. Mackie, F. Baik, H. Li, and H. M. Korchak
Regulation of TNF mediated antiapoptotic signaling in human neutrophils: role of {delta}-PKC and ERK1/2
J. Leukoc. Biol.,
December 1, 2006;
80(6):
1512 - 1521.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Tortorella, O. Simone, G. Piazzolla, I. Stella, V. Cappiello, and S. Antonaci
Role of Phosphoinositide 3-Kinase and Extracellular Signal-Regulated Kinase Pathways in Granulocyte Macrophage-Colony-Stimulating Factor Failure to Delay Fas-Induced Neutrophil Apoptosis in Elderly Humans
J. Gerontol. A Biol. Sci. Med. Sci.,
November 1, 2006;
61(11):
1111 - 1118.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Negrotto, E. Malaver, M. E. Alvarez, N. Pacienza, L. P. D'Atri, R. G. Pozner, R. M. Gomez, and M. Schattner
Aspirin and Salicylate Suppress Polymorphonuclear Apoptosis Delay Mediated by Proinflammatory Stimuli
J. Pharmacol. Exp. Ther.,
November 1, 2006;
319(2):
972 - 979.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Cassatella
On the production of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2L) by human neutrophils
J. Leukoc. Biol.,
June 1, 2006;
79(6):
1140 - 1149.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. J. D. McLaughlin, A. Banerjee, M. R. Kelher, F. Gamboni-Robertson, C. Hamiel, F. R. Sheppard, E. E. Moore, and C. C. Silliman
Platelet-Activating Factor-Induced Clathrin-Mediated Endocytosis Requires beta-Arrestin-1 Recruitment and Activation of the p38 MAPK Signalosome at the Plasma Membrane for Actin Bundle Formation.
J. Immunol.,
June 1, 2006;
176(11):
7039 - 7050.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. Cowburn, A. Sobolewski, B. J. Reed, J. Deighton, J. Murray, K. A. Cadwallader, J. R. Bradley, and E. R. Chilvers
Aminopeptidase N (CD13) Regulates Tumor Necrosis Factor-{alpha}-induced Apoptosis in Human Neutrophils
J. Biol. Chem.,
May 5, 2006;
281(18):
12458 - 12467.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. M. McGettrick, J. M. Lord, K.-Q. Wang, G. E. Rainger, C. D. Buckley, and G. B. Nash
Chemokine- and adhesion-dependent survival of neutrophils after transmigration through cytokine-stimulated endothelium
J. Leukoc. Biol.,
April 1, 2006;
79(4):
779 - 788.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. E. Wesche-Soldato, J. L. Lomas-Neira, M. Perl, L. Jones, C.-S. Chung, and A. Ayala
The role and regulation of apoptosis in sepsis
Innate Immunity,
December 1, 2005;
11(6):
375 - 382.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. J. Lum, G. Bren, R. McClure, and A. D. Badley
Elimination of Senescent Neutrophils by TNF-Related Apotosis-Inducing Ligand
J. Immunol.,
July 15, 2005;
175(2):
1232 - 1238.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. Cowburn, J. F. White, J. Deighton, S. R. Walmsley, and E. R. Chilvers
z-VAD-fmk augmentation of TNF{alpha}-stimulated neutrophil apoptosis is compound specific and does not involve the generation of reactive oxygen species
Blood,
April 1, 2005;
105(7):
2970 - 2972.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Francois, J. El Benna, P. M. C. Dang, E. Pedruzzi, M.-A. Gougerot-Pocidalo, and C. Elbim
Inhibition of Neutrophil Apoptosis by TLR Agonists in Whole Blood: Involvement of the Phosphoinositide 3-Kinase/Akt and NF-{kappa}B Signaling Pathways, Leading to Increased Levels of Mcl-1, A1, and Phosphorylated Bad
J. Immunol.,
March 15, 2005;
174(6):
3633 - 3642.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Nusbaum, C. Laine, M. Bouaouina, S. Seveau, E. M. Cramer, J. M. Masse, P. Lesavre, and L. Halbwachs-Mecarelli
Distinct Signaling Pathways Are Involved in Leukosialin (CD43) Down-regulation, Membrane Blebbing, and Phospholipid Scrambling during Neutrophil Apoptosis
J. Biol. Chem.,
February 18, 2005;
280(7):
5843 - 5853.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Hu, X. Lin, Q. Du, E. J. Miller, P. Wang, and H. H. Simms
Regulation of polymorphonuclear leukocyte apoptosis: role of lung endothelium-epithelium bilayer transmigration
Am J Physiol Lung Cell Mol Physiol,
February 1, 2005;
288(2):
L266 - L274.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. P. Bowler, M. Nicks, K. Tran, G. Tanner, L.-Y. Chang, S. K. Young, and G. S. Worthen
Extracellular Superoxide Dismutase Attenuates Lipopolysaccharide-Induced Neutrophilic Inflammation
Am. J. Respir. Cell Mol. Biol.,
October 1, 2004;
31(4):
432 - 439.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Aleman, P. Schierloh, S. S. de la Barrera, R. M. Musella, M. A. Saab, M. Baldini, E. Abbate, and M. C. Sasiain
Mycobacterium tuberculosis Triggers Apoptosis in Peripheral Neutrophils Involving Toll-Like Receptor 2 and p38 Mitogen Protein Kinase in Tuberculosis Patients
Infect. Immun.,
September 1, 2004;
72(9):
5150 - 5158.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. E. Kilpatrick, S. Sun, and H. M. Korchak
Selective regulation by {delta}-PKC and PI 3-kinase in the assembly of the antiapoptotic TNFR-1 signaling complex in neutrophils
Am J Physiol Cell Physiol,
September 1, 2004;
287(3):
C633 - C642.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Asensi, E. Valle, A. Meana, J. Fierer, A. Celada, V. Alvarez, J. Paz, E. Coto, J. A. Carton, J. A. Maradona, et al.
In Vivo Interleukin-6 Protects Neutrophils from Apoptosis in Osteomyelitis
Infect. Immun.,
July 1, 2004;
72(7):
3823 - 3828.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Matsuyama, M. Yamamoto, I. Higashimoto, K.-i. Oonakahara, M. Watanabe, K. Machida, T. Yoshimura, N. Eiraku, M. Kawabata, M. Osame, et al.
TNF-related apoptosis-inducing ligand is involved in neutropenia of systemic lupus erythematosus
Blood,
July 1, 2004;
104(1):
184 - 191.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Miyazaki, F. Ishikawa, T. Fujikawa, S. Nagata, and K. Yamaguchi
Intraperitoneal Injection of Lipopolysaccharide Induces Dynamic Migration of Gr-1high Polymorphonuclear Neutrophils in the Murine Abdominal Cavity
Clin. Vaccine Immunol.,
May 1, 2004;
11(3):
452 - 457.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. D. Garlichs, S. Eskafi, I. Cicha, A. Schmeisser, B. Walzog, D. Raaz, C. Stumpf, A. Yilmaz, J. Bremer, J. Ludwig, et al.
Delay of neutrophil apoptosis in acute coronary syndromes
J. Leukoc. Biol.,
May 1, 2004;
75(5):
828 - 835.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Goepel, P. Weinmann, J. Schymeinsky, and B. Walzog
Identification of caspase-10 in human neutrophils and its role in spontaneous apoptosis
J. Leukoc. Biol.,
May 1, 2004;
75(5):
836 - 843.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. P. Radsak, H. R. Salih, H.-G. Rammensee, and H. Schild
Triggering Receptor Expressed on Myeloid Cells-1 in Neutrophil Inflammatory Responses: Differential Regulation of Activation and Survival
J. Immunol.,
April 15, 2004;
172(8):
4956 - 4963.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-H. Lee, L. Del Sorbo, A. A. Khine, J. de Azavedo, D. E. Low, D. Bell, S. Uhlig, A. S. Slutsky, and H. Zhang
Modulation of Bacterial Growth by Tumor Necrosis Factor-{alpha} In Vitro and In Vivo
Am. J. Respir. Crit. Care Med.,
December 15, 2003;
168(12):
1462 - 1470.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. H. Zhu and E. L. Schwartz
Expression of the Angiogenic Factor Thymidine Phosphorylase in THP-1 Monocytes: Induction by Autocrine Tumor Necrosis Factor-{alpha} and Inhibition by Aspirin
Mol. Pharmacol.,
November 1, 2003;
64(5):
1251 - 1258.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S Kotecha, R J Mildner, L R Prince, J R Vyas, A E Currie, R A Lawson, and M K B Whyte
The role of neutrophil apoptosis in the resolution of acute lung injury in newborn infants
Thorax,
November 1, 2003;
58(11):
961 - 967.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Comalada, J. Xaus, A. F. Valledor, C. Lopez-Lopez, D. J. Pennington, and A. Celada
PKC{epsilon} is involved in JNK activation that mediates LPS-induced TNF-{alpha}, which induces apoptosis in macrophages
Am J Physiol Cell Physiol,
November 1, 2003;
285(5):
C1235 - C1245.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. A. Rarok, P. C. Limburg, and C. G. M. Kallenberg
Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies
J. Leukoc. Biol.,
July 1, 2003;
74(1):
3 - 15.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. A. Maianski, D. Roos, and T. W. Kuijpers
Tumor necrosis factor alpha induces a caspase-independent death pathway in human neutrophils
Blood,
March 1, 2003;
101(5):
1987 - 1995.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. A. Renshaw, J. S. Parmar, V. Singleton, S. J. Rowe, D. H. Dockrell, S. K. Dower, C. D. Bingle, E. R. Chilvers, and M. K. B. Whyte
Acceleration of Human Neutrophil Apoptosis by TRAIL
J. Immunol.,
January 15, 2003;
170(2):
1027 - 1033.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Knapp, J. C. Leemans, S. Florquin, J. Branger, N. A. Maris, J. Pater, N. van Rooijen, and T. van der Poll
Alveolar Macrophages Have a Protective Antiinflammatory Role during Murine Pneumococcal Pneumonia
Am. J. Respir. Crit. Care Med.,
January 15, 2003;
167(2):
171 - 179.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C.-Y. Liu, A. Takemasa, W. C. Liles, R. B. Goodman, M. Jonas, H. Rosen, E. Chi, R. K. Winn, J. M. Harlan, and P. I. Chuang
Broad-spectrum caspase inhibition paradoxically augments cell death in TNF-alpha -stimulated neutrophils
Blood,
January 1, 2003;
101(1):
295 - 304.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. C. MacKinnon, A. Buckley, E. R. Chilvers, A. G. Rossi, C. Haslett, and T. Sethi
Sphingosine Kinase: A Point of Convergence in the Action of Diverse Neutrophil Priming Agents
J. Immunol.,
December 1, 2002;
169(11):
6394 - 6400.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Ottonello, M. Cutolo, G. Frumento, N. Arduino, M. Bertolotto, M. Mancini, E. Sottofattori, and F. Dallegri
Synovial fluid from patients with rheumatoid arthritis inhibits neutrophil apoptosis: role of adenosine and proinflammatory cytokines
Rheumatology,
November 1, 2002;
41(11):
1249 - 1260.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Schettini, G. Salamone, A. Trevani, S. Raiden, R. Gamberale, M. Vermeulen, M. Giordano, and J. R. Geffner
Stimulation of neutrophil apoptosis by immobilized IgA
J. Leukoc. Biol.,
October 1, 2002;
72(4):
685 - 691.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Castro-Alcaraz, V. Miskolci, B. Kalasapudi, D. Davidson, and I. Vancurova
NF-{kappa}B Regulation in Human Neutrophils by Nuclear I{kappa}B{alpha}: Correlation to Apoptosis
J. Immunol.,
October 1, 2002;
169(7):
3947 - 3953.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. I. Mecklenburgh, S. R. Walmsley, A. S. Cowburn, M. Wiesener, B. J. Reed, P. D. Upton, J. Deighton, A. P. Greening, and E. R. Chilvers
Involvement of a ferroprotein sensor in hypoxia-mediated inhibition of neutrophil apoptosis
Blood,
September 26, 2002;
100(8):
3008 - 3016.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. Cowburn, K. A. Cadwallader, B. J. Reed, N. Farahi, and E. R. Chilvers
Role of PI3-kinase-dependent Bad phosphorylation and altered transcription in cytokine-mediated neutrophil survival
Blood,
September 18, 2002;
100(7):
2607 - 2616.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. E. Kilpatrick, J. Y. Lee, K. M. Haines, D. E. Campbell, K. E. Sullivan, and H. M. Korchak
A role for PKC-delta and PI 3-kinase in TNF-alpha -mediated antiapoptotic signaling in the human neutrophil
Am J Physiol Cell Physiol,
July 1, 2002;
283(1):
C48 - C57.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Ward, I. Dransfield, J. Murray, S. N. Farrow, C. Haslett, and A. G. Rossi
Prostaglandin D2 and Its Metabolites Induce Caspase-Dependent Granulocyte Apoptosis That Is Mediated Via Inhibition of I{kappa}B{alpha} Degradation Using a Peroxisome Proliferator-Activated Receptor-{gamma}-Independent Mechanism
J. Immunol.,
June 15, 2002;
168(12):
6232 - 6243.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Raqib, C. Ekberg, P. Sharkar, P. K. Bardhan, A. Zychlinsky, P. J. Sansonetti, and J. Andersson
Apoptosis in Acute Shigellosis Is Associated with Increased Production of Fas/Fas Ligand, Perforin, Caspase-1, and Caspase-3 but Reduced Production of Bcl-2 and Interleukin-2
Infect. Immun.,
June 1, 2002;
70(6):
3199 - 3207.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. S. Parmar, R. Mahadeva, B. J. Reed, N. Farahi, K. A. Cadwallader, M. T. Keogan, D. Bilton, E. R. Chilvers, and D. A. Lomas
Polymers of alpha 1-Antitrypsin Are Chemotactic for Human Neutrophils . A New Paradigm for the Pathogenesis of Emphysema
Am. J. Respir. Cell Mol. Biol.,
June 1, 2002;
26(6):
723 - 730.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Kooijman, A. Coppens, and E. Hooghe-Peters
IGF-I Inhibits Spontaneous Apoptosis in Human Granulocytes
Endocrinology,
April 1, 2002;
143(4):
1206 - 1212.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Lacoste, A. Cueff, and S. A. Poulet
P35-sensitive caspases, MAP kinases and Rho modulate {beta}-adrenergic induction of apoptosis in mollusc immune cells
J. Cell Sci.,
February 15, 2002;
115(4):
761 - 768.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Nijhuis, J.-W. J Lammers, L. Koenderman, and P. J. Coffer
Src kinases regulate PKB activation and modulate cytokine and chemoattractant-controlled neutrophil functioning
J. Leukoc. Biol.,
January 1, 2002;
71(1):
115 - 124.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Moulding, C. Akgul, M. Derouet, M. R. H. White, and S. W. Edwards
BCL-2 family expression in human neutrophils during delayed and accelerated apoptosis
J. Leukoc. Biol.,
November 1, 2001;
70(5):
783 - 792.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Amrani, A. J. Ammit, and R. A. Panettieri Jr.
Tumor Necrosis Factor Receptor (TNFR) 1, but Not TNFR2, Mediates Tumor Necrosis Factor-alpha -Induced Interleukin-6 and RANTES in Human Airway Smooth Muscle Cells: Role of p38 and p42/44 Mitogen-Activated Protein Kinases
Mol. Pharmacol.,
October 1, 2001;
60(4):
646 - 655.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Wislez, J. Fleury-Feith, N. Rabbe, J. Moreau, D. Cesari, B. Milleron, C. Mayaud, M. Antoine, P. Soler, and J. Cadranel
Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor and Granulocyte Colony-Stimulating Factor Prolong the Survival of Neutrophils Infiltrating Bronchoalveolar Subtype Pulmonary Adenocarcinoma
Am. J. Pathol.,
October 1, 2001;
159(4):
1423 - 1433.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
V. Rumalla, S. E. Calvano, A. J. Spotnitz, T. J. Krause, E. Lin, and S. F. Lowry
The Effects of Glucocorticoid Therapy on Inflammatory Responses to Coronary Artery Bypass Graft Surgery
Arch Surg,
September 1, 2001;
136(9):
1039 - 1044.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. van den Berg, S. Weyer, J. J. Weening, D. Roos, and T. W. Kuijpers
Divergent effects of tumor necrosis factor {alpha} on apoptosis of human neutrophils
J. Leukoc. Biol.,
March 1, 2001;
69(3):
467 - 473.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
G. Salamone, M. Giordano, A. S. Trevani, R. Gamberale, M. Vermeulen, J. Schettinni, and J. R. Geffner
Promotion of Neutrophil Apoptosis by TNF-{{alpha}}
J. Immunol.,
March 1, 2001;
166(5):
3476 - 3483.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Bureau, S. Delhalle, G. Bonizzi, L. Fievez, S. Dogne, N. Kirschvink, A. Vanderplasschen, M.-P. Merville, V. Bours, and P. Lekeux
Mechanisms of Persistent NF-{kappa}B Activity in the Bronchi of an Animal Model of Asthma
J. Immunol.,
November 15, 2000;
165(10):
5822 - 5830.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Kettritz, Y.-X. Xu, B. Faass, J. B. Klein, E.-C. Müller, A. Otto, A. Busjahn, F. C. Luft, and H. Haller
TNF-{alpha}-mediated neutrophil apoptosis involves Ly-GDI, a Rho GTPase regulator
J. Leukoc. Biol.,
August 1, 2000;
68(2):
277 - 283.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
A. J. Meszaros, J. S. Reichner, and J. E. Albina
Macrophage-Induced Neutrophil Apoptosis
J. Immunol.,
July 1, 2000;
165(1):
435 - 441.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Harper, Y. Ren, J. Savill, D. Adu, and C. O. S. Savage
Antineutrophil Cytoplasmic Antibodies Induce Reactive Oxygen-Dependent Dysregulation of Primed Neutrophil Apoptosis and Clearance by Macrophages
Am. J. Pathol.,
July 1, 2000;
157(1):
211 - 220.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Xaus, M. Comalada, A. F. Valledor, J. Lloberas, F. Lopez-Soriano, J. M. Argiles, C. Bogdan, and A. Celada
LPS induces apoptosis in macrophages mostly through the autocrine production of TNF-alpha
Blood,
June 15, 2000;
95(12):
3823 - 3831.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. P. Mizgerd, J. J. Peschon, and C. M. Doerschuk
Roles of Tumor Necrosis Factor Receptor Signaling during Murine Escherichia coli Pneumonia
Am. J. Respir. Cell Mol. Biol.,
January 1, 2000;
22(1):
85 - 91.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
B. Dibbert, M. Weber, W. H. Nikolaizik, P. Vogt, M. H. Schoni, K. Blaser, and H.-U. Simon
Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: A general mechanism to accumulate effector cells in inflammation
PNAS,
November 9, 1999;
96(23):
13330 - 13335.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. HASLETT
Granulocyte Apoptosis and Its Role in the Resolution and Control of Lung Inflammation
Am. J. Respir. Crit. Care Med.,
November 1, 1999;
160(5):
S5 - 11.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Laouar, D. Glesne, and E. Huberman
Involvement of Protein Kinase C-beta and Ceramide in Tumor Necrosis Factor-alpha -induced but Not Fas-induced Apoptosis of Human Myeloid Leukemia Cells
J. Biol. Chem.,
August 13, 1999;
274(33):
23526 - 23534.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Moulding, C. Walter, C. A. Hart, and S. W. Edwards
Effects of Staphylococcal Enterotoxins on Human Neutrophil Functions and Apoptosis
Infect. Immun.,
May 1, 1999;
67(5):
2312 - 2318.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Ward, E. R. Chilvers, M. F. Lawson, J. G. Pryde, S. Fujihara, S. N. Farrow, C. Haslett, and A. G. Rossi
NF-kappa B Activation Is a Critical Regulator of Human Granulocyte Apoptosis in Vitro
J. Biol. Chem.,
February 12, 1999;
274(7):
4309 - 4318.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Yamashita, A. Takahashi, S. Kobayashi, H. Hirata, P. W. Mesner Jr, S. H. Kaufmann, S. Yonehara, K. Yamamoto, T. Uchiyama, and M. Sasada
Caspases Mediate Tumor Necrosis Factor-alpha -Induced Neutrophil Apoptosis and Downregulation of Reactive Oxygen Production
Blood,
January 15, 1999;
93(2):
674 - 685.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E R CHILVERS, A G ROSSI, J MURRAY, and C HASLETT
Regulation of granulocyte apoptosis and implications for anti-inflammatory therapy
Thorax,
July 1, 1998;
53(7):
533 - 534.
[Full Text]
|
|
|
|
|
|
|
N. Cheng and J. Chen
Tumor Necrosis Factor-alpha Induction of Endothelial Ephrin A1 Expression Is Mediated by a p38 MAPK- and SAPK/JNK-dependent but Nuclear Factor-kappa B-independent Mechanism
J. Biol. Chem.,
April 20, 2001;
276(17):
13771 - 13777.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Soler, R. Valdes, J. Garcia-Manteiga, J. Xaus, M. Comalada, F. J. Casado, M. Modolell, B. Nicholson, C. MacLeod, A. Felipe, et al.
Lipopolysaccharide-induced Apoptosis of Macrophages Determines the Up-regulation of Concentrative Nucleoside Transporters Cnt1 and Cnt2 through Tumor Necrosis Factor-alpha -dependent and -independent Mechanisms
J. Biol. Chem.,
August 3, 2001;
276(32):
30043 - 30049.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
Abstract
Introduction
Abstract